In the BioHarmony Drug Report Database

"Preview" Icon

Corticotropin

Acth, Acthar, Corticotropin, H.p. Acthar Gel, Purified Cortrophin Gel (corticotropin) is a protein pharmaceutical. Corticotropin was first approved as Acth on 1982-01-01. It is used to treat collagen diseases, erythema multiforme, infantile spasms, multiple sclerosis, and nephrotic syndrome amongst others in the USA. The pharmaceutical is active against adrenocorticotropic hormone receptor. In addition, it is known to target CRHR1-IT1-CRHR1 protein, melanocortin receptor 5, melanocortin receptor 4, melanocyte-stimulating hormone receptor, melanocortin receptor 3, and corticotropin-releasing factor receptor 2.

 

Trade Name

 

Acth, Acthar, Corticotropin, H.p. Acthar Gel, Purified Cortrophin Gel
 

Common Name

 

corticotropin
 

ChEMBL ID

 

CHEMBL1201610
 

Indication

 

collagen diseases, erythema multiforme, infantile spasms, multiple sclerosis, nephrotic syndrome, optic neuritis, rheumatic diseases, sarcoidosis, serum sickness, uveitis
 

Drug Class

 

Atropine derivatives

Image (chem structure or protein)

Corticotropin structure rendering